Literature DB >> 18351296

A general approach to the apparent permeability index.

Pasquale Palumbo1, Umberto Picchini, Benoît Beck, Jan van Gelder, Nathalie Delbar, Andrea DeGaetano.   

Abstract

The apparent permeability index is widely used as part of a general screening process to study drug absorption, and is routinely obtained from in vitro or ex vivo experiments. A classical example, widely used in the pharmaceutical industry, is the in vitro Caco-2 cell culture model. The index is defined as the initial flux of compound through the membrane (normalized by membrane surface area and donor concentration) and is typically computed by adapting a straight line to the initial portion of the recorded amounts in the receiver compartment, possibly disregarding the first few points when lagging of the transfer process through the membrane is evident. Modeling the transfer process via a two-compartmental system yields an immediate analogue of the common Papp as the initial slope of the receiver quantity, but the two-compartment model often does not match observations well. A three-compartment model, describing the cellular layer as well as donor and receiver compartments, typically better represents the kinetics, but has the disadvantage of always having zero initial flow rate to the receiver compartment: in these circumstances the direct analogue of the Papp index is not informative since it is always zero. In the present work an alternative definition of an apparent permeability index is proposed for three-compartment models, and is shown to reduce to the classical formulation as the cellular layer's volume tends towards zero. This new index characterizes the intrinsic permeability of the membrane to the compound under investigation, can be directly computed in a completely observer-independent fashion, and reduces to the usual Papp when the linear two-compartment representation is sufficient to accurately describe compound kinetics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351296     DOI: 10.1007/s10928-008-9086-4

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  7 in total

Review 1.  Caco-2 monolayers in experimental and theoretical predictions of drug transport.

Authors:  P Artursson; K Palm; K Luthman
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.

Authors:  Alex Avdeef; Per Artursson; Sibylle Neuhoff; Lucia Lazorova; Johan Gråsjö; Staffan Tavelin
Journal:  Eur J Pharm Sci       Date:  2005-01-20       Impact factor: 4.384

3.  Prediction of the permeability of drugs through study on quantitative structure-permeability relationship.

Authors:  Seo Jeong Jung; Sun Ok Choi; So Young Um; Joo Il Kim; Hae Young Park Choo; Su Young Choi; Soo Youn Chung
Journal:  J Pharm Biomed Anal       Date:  2006-02-03       Impact factor: 3.935

4.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

5.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

6.  Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.

Authors:  K Palm; K Luthman; J Ros; J Grasjo; P Artursson
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

7.  Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers.

Authors:  Pratik Saha; Jim H Kou
Journal:  Eur J Pharm Biopharm       Date:  2002-11       Impact factor: 5.571

  7 in total
  9 in total

1.  Combining Chemical Permeation Enhancers for Synergistic Effects.

Authors:  Trizel du Toit; Maides M Malan; Hendrik J R Lemmer; Chrisna Gouws; Marique E Aucamp; Wilma J Breytenbach; Josias H Hamman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

2.  Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus)

Authors:  Prasad Neerati; Sangeethkumar Munigadapa
Journal:  Turk J Pharm Sci       Date:  2022-02-28

3.  Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.

Authors:  Max I Bogorad; Peter C Searson
Journal:  Integr Biol (Camb)       Date:  2016-08-15       Impact factor: 2.192

4.  Droplet-interface-bilayer assays in microfluidic passive networks.

Authors:  Bárbara Schlicht; Michele Zagnoni
Journal:  Sci Rep       Date:  2015-04-24       Impact factor: 4.379

5.  Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations.

Authors:  Crystal B Spinks; Ahmed S Zidan; Mansoor A Khan; Muhammad J Habib; Patrick J Faustino
Journal:  Clin Pharmacol       Date:  2017-02-23

6.  GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.

Authors:  Erika Di Biase; Giulia Lunghi; Margherita Maggioni; Maria Fazzari; Diego Yuri Pomè; Nicoletta Loberto; Maria Grazia Ciampa; Pamela Fato; Laura Mauri; Emmanuel Sevin; Fabien Gosselet; Sandro Sonnino; Elena Chiricozzi
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

7.  Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers.

Authors:  Rehab A Alshammari; Fadilah S Aleanizy; Amal Aldarwesh; Fulwah Y Alqahtani; Wael A Mahdi; Bushra Alquadeib; Qamraa H Alqahtani; Nazrul Haq; Faiyaz Shakeel; Hosam G Abdelhady; Ibrahim A Alsarra
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

8.  Hyperbranched polydendrons: a new nanomaterials platform with tuneable permeation through model gut epithelium.

Authors:  Fiona L Hatton; Lee M Tatham; Louise R Tidbury; Pierre Chambon; Tao He; Andrew Owen; Steven P Rannard
Journal:  Chem Sci       Date:  2014-10-03       Impact factor: 9.825

9.  Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments.

Authors:  Aroha B Sánchez; Ana C Calpena; Mireia Mallandrich; Beatriz Clares
Journal:  Pharmaceutics       Date:  2019-11-29       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.